Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | AR | P10275 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | MAPK11 | Q15759 | 2/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | TNF | P01375 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9613085 | 0.92 | ALDH1A1 (0.48) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL13658690 | 0.88 | RAB9A (0.45) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL13658717 | 0.87 | KMT2A (0.38) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL14461161 | 0.85 | MAPT (0.55) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL13658711 | 0.85 | CYP11B1 (0.45) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL13658709 | 0.84 | CYP1A2 (0.42) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL9612925 | 0.82 | MAPT (0.53) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL17754136 | 0.81 | MEN1 (0.53) | RAB9AMAPTKDM4EALDH1A1HPGD | |
| SCHEMBL18718020 | 0.81 | RAB9A (0.44) | RAB9AMAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL12435745 | 0.80 | PIM1 (0.50) | RAB9AMAPTNPC1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-9887365-B2 | Organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-02-06 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-20160141513-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-05-19 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| US-9296695-B2 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-29 | — | — | US | disclosed |
| EP-2110373-B1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | SAMSUNG DISPLAY CO LTD (KR) | 2012-11-21 | — | — | EP | disclosed |
| EP-2110373-A1 | Bipyridine-based compound and organic light emitting diode employing organic layer comprising the same | Samsung Mobile Display Co., Ltd. (KR) | 2009-10-21 | — | — | EP | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090256473-A1 | BIPYRIDINE-BASED COMPOUND AND ORGANIC LIGHT EMITTING DIODE EMPLOYING ORGANIC LAYER COMPRISING THE SAME | OCIAD2, OCIAD1, DRD2 | RAB9A 1437/4885MAPT 214/4885NPC1 1078/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.